Türkiye’s Healthcare Evolution Attracts Global Patients
Türkiye's healthcare evolution attracts global patients with advanced treatments and quality care.
Featured Stories
All Stories →Yogurt Linked to Lower Heart Disease Risk
Yogurt appears on many nutrition lists, but recent research highlights its potential as a longevity food, offering protein, minerals and…
New study questions BMI as health indicator
New study questions BMI as health indicator, overlooking metabolic health signals in adults.
New Prostate Cancer Screening Guidelines Recommend Testing for Middle-Aged Men
New prostate cancer screening guidelines recommend testing for middle-aged men, addressing years of ambiguity in PSA testing advice.
BP Trends
More →Diet Links
More →Monitor Picks
More →Stress Checks
More →Drug Doses
More →Popular Posts
Refresh ↺FDA approves Mounjaro for diabetes heart risk reduction
FDA approves Mounjaro for diabetes to reduce heart risks in adults. This new approval lowers risks of major adverse cardiovascular…
Margaret Murray Critiques Republicans on Medicaid Stance
Margaret Murray critiques Republicans on Medicaid stance, calling the overhaul's provisions, including work requirements and redetermination cycles, deeply conc
Eating Disorders And Body Image: The Universal Link
Body image is something that everyone, one way or another, has to deal with in their lifetime. When you look…
New study questions BMI as health indicator
New study questions BMI as health indicator, overlooking metabolic health signals in adults.
FDA clears new drug for rare skin condition
The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted treatment.
FDA approves new drug for rare bone disease
The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900 people worldwide.
